The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process
Open accessAbstract
BACKGROUND: Prostate cancer is characterized by heterogeneity in the clinical course that often does not correlate with morphologic features of the tumor. Metastasis reflects the most adverse outcome of prostate cancer, and to date there are no reliable morphologic features or serum biomarkers that can reliably predict which patients are at higher risk of developing metastatic disease. Understanding the differences in the biology of metastatic and organ confined primary tumors is essential for developing new prognostic markers and therapeutic targets. METHODS: Using Affymetrix oligonucleotide arrays, we analyzed gene expression profiles of 24 androgen-ablation resistant metastatic samples obtained from 4 patients and a previously published dataset of 64 primary prostate tumor samples. Differential gene expression was analyzed after removing potentially uninformative stromal genes, addressing the differences in cellular content between primary and metastatic tumors. RESULTS: The metastatic samples are highly heterogenous in expression; however, differential expression analysis shows that 415 genes are upregulated and 364 genes are downregulated at least 2 fold in every patient with metastasis. The expression profile of metastatic samples reveals changes in expression of a unique set of genes representing both the androgen ablation related pathways and other metastasis related gene networks such as cell adhesion, bone remodelling and cell cycle. The differentially expressed genes include metabolic enzymes, transcription factors such as Forkhead Box M1 (FoxM1) and cell adhesion molecules such as Osteopontin (SPP1). CONCLUSION: We hypothesize that these genes have a role in the biology of metastatic disease and that they represent potential therapeutic targets for prostate cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
(1968) · American Association of Industrial Nurses Journal · doi:10.1177/216507996801601208 · Cited by 8,798
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cordón-Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,597
Gene expression correlates of clinical prostate cancer behavior
Singh, D., Febbo, P. G., Ross, K., Jackson, D. G., Manola, J., Ladd, C., Tamayo, P., Renshaw, A. A., D'Amico, A. V., Richie, J. P., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00030-2 · Cited by 2,512
Molecular determinants of resistance to antiandrogen therapy
Chen, C. D., Welsbie, D. S., Tran, C., Baek, S. H., Chen, R., Vessella, R., Rosenfeld, M. G., & Sawyers, C. L. (2004) · Nature Medicine · doi:10.1038/nm972 · Cited by 2,278
Delineation of prognostic biomarkers in prostate cancer
Dhanasekaran, S. M., Barrette, T. R., Ghosh, D., Shah, R., Varambally, S., Kurachi, K., Pienta, K. J., Rubin, M. A., & Chinnaiyan, A. M. (2001) · Nature · doi:10.1038/35090585 · Cited by 1,673
Stanbrough, M., Bubley, G. J., Ross, K., Golub, T. R., Rubin, M. A., Penning, T. M., Febbo, P. G., & Balk, S. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4000 · Cited by 1,082
Yu, Y. P., Landsittel, D., Jing, L., Nelson, J., Ren, B., Liu, L., McDonald, C., Thomas, R., Dhir, R., Finkelstein, S., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.158 · Cited by 758
Self-citationA module map showing conditional activity of expression modules in cancer
Segal, E., Friedman, N., Koller, D., & Regev, A. (2004) · Nature Genetics · doi:10.1038/ng1434 · Cited by 685
Androgen-Independent Prostate Cancer Is a Heterogeneous Group of Diseases
Shah, R. B., Mehra, R., Chinnaiyan, A. M., Shen, R., Ghosh, D., Zhou, M., MacVicar, G. R., Varambally, S., Harwood, J., Bismar, T. A., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2442 · Cited by 617
Osteoblasts in prostate cancer metastasis to bone
Logothetis, C. J., & Lin, S.-H. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1528 · Cited by 614
Holzbeierlein, J., Lal, P., LaTulippe, E., Smith, A., Satagopan, J., Zhang, L., Ryan, C., Smith, S., Scher, H., Scardino, P., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63112-4 · Cited by 577 · cited 5×
“Unique profiles have been reported for untreated and short-term androgen ablation treated organ-confined disease and for metastatic disease, with a subset of genes differentiating metastatic androgen ablation resistant prostate cancer (AARPC) from androgen dependent metastatic cancers [10,12-14].”
BackgroundResultInfluentialLatulippe, É., Satagopan, J. M., Smith, A., Scher, H. I., Scardino, P. T., Reuter, V. E., & Gerald, W. L. (2002) · PubMed · Cited by 518
The role of Osteopontin in tumor metastasis
Wai, P. Y., & Kuo, P. C. (2004) · Journal of Surgical Research · doi:10.1016/j.jss.2004.03.028 · Cited by 365
Zhou, M., Chinnaiyan, A. M., Kleer, C. G., Lucas, P. C., & Rubin, M. A. (2002) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200207000-00012 · Cited by 297
A molecular correlate to the Gleason grading system for prostate adenocarcinoma
True, L., Coleman, I., Hawley, S., Huang, C.-Y., Gifford, D., Coleman, R., Beer, T. M., Gelmann, E., Datta, M., Mostaghel, E., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603678103 · Cited by 291
The metastasis gene osteopontin: a candidate target for cancer therapy
Weber, G. F. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(01)00037-3 · Cited by 286
Kalin, T. V., Wang, I.-C., Ackerson, T. J., Major, M. L., Detrisac, C. J., Kalinichenko, V. V., Lyubimov, A., & Costa, R. H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3138 · Cited by 274
HERMANI, A., DESERVI, B., MEDUNJANIN, S., TESSIER, P., & MAYER, D. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.10.013 · Cited by 262
Barnes, M. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki890 · Cited by 255
P700: the primary electron donor of photosystem I
Webber, A. N., & Lubitz, W. (2001) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(01)00198-0 · Cited by 251
Calcium-Binding Proteins S100A8 and S100A9 as Novel Diagnostic Markers in Human Prostate Cancer
Hermani, A., Hess, J., De Servi, B., Medunjanin, S., Grobholz, R., Trojan, L., Angel, P., & Mayer, D. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0352 · Cited by 247
Gene expression analysis of prostate cancers
Luo, J., Yu, Y. P., Cieply, K., Lin, F., Deflavia, P., Dhir, R., Finkelstein, S., Michalopoulos, G., & Becich, M. (2002) · Molecular Carcinogenesis · doi:10.1002/mc.10018 · Cited by 235
Self-citationThe Functional and Clinical Roles of Osteopontin in Cancer and Metastasis
Furger, K. A., Menon, R. K., Tuck, A. B., Bramwell, V. H. C., & Chambers, A. F. (2001) · Current Molecular Medicine · doi:10.2174/1566524013363339 · Cited by 217
In silico dissection of cell-type-associated patterns of gene expression in prostate cancer
Stuart, R. O., Wachsman, W., Berry, C. C., Wang-Rodriguez, J., Wasserman, L., Klacansky, I., Masys, D., Arden, K., Goodison, S., McClelland, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2536479100 · Cited by 198
Stewart, D. A., Cooper, C. R., & Sikes, R. A. (2004) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-2-2 · Cited by 168
(2002) · PubMed · Cited by 162
Hotte, S. J., Winquist, E. W., Stitt, L., Wilson, S. M., & Chambers, A. F. (2002) · Cancer · doi:10.1002/cncr.10709 · Cited by 161
Chandran, U. R., Dhir, R., Ma, C., Michalopoulos, G., Becich, M., & Gilbertson, J. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-45 · Cited by 160
Self-citationAmler, L. C., Agus, D. B., LeDuc, C. A., Sapinoso, M. L., Fox, W. D., Kern, S. G., Lee, D., Wang, V., Leysens, M., Higgins, B., et al. (2000) · PubMed · Cited by 149
Defining Aggressive Prostate Cancer Using a 12-Gene Model
Bismar, T. A., Demichelis, F., Riva, A., Kim, R., Varambally, S., He, L., Kutok, J. L., Aster, J. C., Tang, J., Kuefer, R., et al. (2006) · Neoplasia · doi:10.1593/neo.05664 · Cited by 107
Prognostic significance of osteopontin expression in human prostate cancer
Forootan, S. S., Foster, C. S., Aachi, V., Adamson, J., Smith, P. H., Lin, K., & Ke, Y. (2005) · International Journal of Cancer · doi:10.1002/ijc.21619 · Cited by 96
Reinholz, M. M., Iturria, S. J., Ingle, J. N., & Roche, P. C. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1016339120506 · Cited by 86
Tumor-bone cellular interactions in skeletal metastases.
Chirgwin, J. M., Mohammad, K. S., & Guise, T. A. (2004) · PubMed · Cited by 72
Chetcuti, A., Margan, S. H., Mann, S., Russell, P., Handelsman, D. J., Rogers, J. H., & Dong, Q. (2001) · The Prostate · doi:10.1002/pros.1056 · Cited by 70
Zlot, C. H., Ingle, G. S., Hongo, J.-A. S., Yang, S., Sheng, Z., SCHWALL, R. H., Paoni, N. F., Wang, F., Peale, F. V., Jr., & Gerritsen, M. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301353200 · Cited by 62
Platform influence on DNA microarray data in postmortem brain research
Hollingshead, D. J., Lewis, D. A., & Mirnics, K. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.10.020 · Cited by 50
Molecular roles of MAP kinases and FADD phosphorylation in prostate cancer.
Shimada, K., Nakamura, M., Ishida, E., & Konishi, N. (2006) · PubMed · doi:10.14670/hh-21.415 · Cited by 48
Sirotnak, F. M., She, Y., Khokhar, N. Z., Hayes, P., Gerald, W. L., & Scher, H. I. (2004) · Molecular Carcinogenesis · doi:10.1002/mc.20051 · Cited by 47
Expression analysis and prognostic significance of human kallikrein 11 in prostate cancer
Stavropoulou, P., Gregorakis, A. K., Plebani, M., et al. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.03.026 · Cited by 38
Ma, C., Lyons‐Weiler, M. A., Liang, W., LaFramboise, W. A., Gilbertson, J. R., Becich, M. J., & Monzon, F. A. (2006) · Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2006.050077 · Cited by 31
Self-citationCurrent Thoughts on the Role of the Androgen Receptor and Prostate Cancer Progression
Setlur, S. R., & Rubin, M. A. (2005) · Advances in Anatomic Pathology · doi:10.1097/01.pap.0000184179.50672.f7 · Cited by 24
Hulboy, D. L., Matrisian, L. M., & Crawford, H. C. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.16.5478-5487.2001 · Cited by 22
Cited by
The Molecular Taxonomy of Primary Prostate Cancer
Abeshouse, A., Ahn, J., Akbani, R., Ally, A., Amin, S., Andry, C. D., Annala, M., Aprikian, A., Armenia, J., Arora, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.10.025 · Cited by 3,110
Self-citationReprogramming transcription by distinct classes of enhancers functionally defined by eRNA
Wang, D., Garcia-Bassets, I., Benner, C., Li, W., Su, X., Zhou, Y., Qiu, J., Liu, W., Kaikkonen, M. U., Ohgi, K. A., et al. (2011) · Nature · doi:10.1038/nature10006 · Cited by 827
FOXM1: From cancer initiation to progression and treatment
Koo, C.-Y., Muir, K. W., & Lam, E. W.-F. (2012) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2011.09.004 · Cited by 406
The Pivotal Regulatory Landscape of RNA Modifications
Li, S., & Mason, C. E. (2014) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090413-025405 · Cited by 374
FOXM1, a typical proliferation-associated transcription factor
Wierstra, I., & Alves, J. (2007) · bchm · doi:10.1515/bc.2007.159 · Cited by 313
Metadata
- Authors
- Chandran, U. R., Ma, C., Dhir, R., Bisceglia, M., Lyons-Weiler, M., Liang, W., Michalopoulos, G., Becich, M., & Monzon, F. A.
- Venue
- BMC Cancer
- Published
- 2007-04-12
- Volume
- 7
- Issue
- 1
- Pages
- 64-64
- ISSN
- 1471-2407 (ISSN-L)
- OpenAlex
- W1968445925
- Cited by
- 495
- References
- 47
- FWCI
- 14.06
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.